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A B S T R A C T
Background
Pelvic organ prolapse is common, with some degree of prolapse seen in up to 50% of parous women in a clinic setting, although many
are asymptomatic. The use of pessaries (a passive mechanical device designed to support the vagina) to treat prolapse is very common,
and up to 77% of clinicians use pessaries for the first line management of prolapse. A number of symptoms may be associated with
prolapse and treatments include surgery, pessaries and conservative therapies. A variety of pessaries are described which aim to alleviate
the symptoms of prolapse and avert or delay the need for surgery.
Objectives
To determine the effectiveness of pessaries (mechanical devices) for pelvic organ prolapse.
Search methods
We searched the Cochrane Incontinence Group Specialised Register of trials (searched 13 March 2012), which includes searches of
CENTRAL,MEDLINE, PREMEDLINE and handsearching of conference proceedings, and handsearched the abstracts of two relevant
conferences held in 2011. We also searched the reference lists of relevant articles.
Selection criteria
Randomised and quasi-randomised controlled trials which included a pessary for pelvic organ prolapse in one arm of the study.
Data collection and analysis
Abstracts were assessed independently by two authors with arbitration from a third if necessary. Data extraction was completed
independently for included studies by two review authors.
Main results
To date there is only one published randomised controlled trial assessing the use of pessaries in the treatment of pelvic organ prolapse.
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Authors’ conclusions
The review authors identified one randomised controlled trial comparing ring andGellhornpessaries. The results of the trial showed that
both pessaries were effective for the approximately 60% of women who completed the study with no significant differences identified
between the two types of pessary. However, methodological flaws were noted in the trial, as elaborated under risk of bias assessment.
There is no consensus on the use of different types of device, the indications nor the pattern of replacement and follow-up care. There
is an urgent need for randomised studies to address the use of pessaries in comparison with no treatment, surgery and conservative
measures.
P L A I N L A N G U A G E S U M M A R Y
Pessaries (mechanical devices) for managing pelvic organ prolapse in women
Pelvic organs, such as the uterus, bladder or bowel, may protrude into the vagina because of weakness in the tissues that normally
support them. The symptoms that they cause vary depending on the type of prolapse. Pessaries (mechanical devices such as latex or
silicone pessaries) can be used to try to restore the prolapsed organs to their normal position and hence to relieve symptoms. They are
commonly used when conservative treatment, like physiotherapy, and surgery have either failed or are not suitable. The review found
one randomised trial which compared two types of pessary, the ring pessary and the Gellhorn pessary. Both pessaries worked for the
60% of women who completed the study and there were no differences between the two types of pessary.
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B A C K G R O U N D
Description of the condition
Pelvic organprolapse is commonand is seen inup to50%of parous
women in a clinic setting (Swift 2000). In the general population,
an estimated 30% of women will have signs of prolapse although
the majority are asymptomatic (Samuelsson 1999). MacLennan
found in telephone interviews that only 8.8% of women in the
general population are symptomatic (MacLennan 2000). Pelvic
organ prolapse includes anterior vaginal wall prolapse (cystocoele,
urethrocoele), posterior vaginal wall prolapse (enterocoele, recto-
coele, perineal deficiency) and uterine or vaginal vault prolapse. A
woman can present with prolapse of one ormore of these sites. The
International Continence Society has standardised the nomencla-
ture using the POP-Q evaluation (Bump 1996), but in this doc-
ument we have also used the descriptive terms above as these are
compatible with searches of the literature.
The aetiology of pelvic organ prolapse is complex and multi-fac-
torial. Risk factors include pregnancy, childbirth, congenital or
acquired connective tissue abnormalities, denervation or weakness
of the pelvic floor, ageing, menopause and factors associated with
chronically raised intra-abdominal pressure such as obesity, cough
and heavy lifting (Bump 1998; MacLennan 2000; Dietz 2008).
Women with prolapse may have a variety of pelvic floor symp-
toms (Hagen 2009; Lone 2011). Only some of the symptoms are
directly related to the prolapse, including pelvic heaviness, a drag-
ging sensation in the vagina, a bulge, lump or protrusion coming
down from the vagina and backache. Symptoms of bladder, bowel
or sexual dysfunction are frequently present. These symptomsmay
be directly related to the prolapsed organ, for example a poor uri-
nary stream when a cystocoele is present or obstructed defecation
when a rectocoele is present. They may also be independent of the
prolapse, for example symptoms of detrusor overactivity when a
cystocoele is present. Symptoms may negatively affect body im-
age, quality of life and a woman’s ability to perform day to day
activities (Lowder 2011).
Description of the intervention
Prolapse treatment may be dependent on a number of factors in-
cluding the severity of prolapse, the bothersomeness of the asso-
ciated symptoms, the woman’s general health and the woman’s
treatment preference (Kapoor 2009; Basu 2011). Options avail-
able for treatment are conservative (for example pelvic floor mus-
cle training), mechanical support (such as vaginal pessaries), oe-
strogens and surgery. Previously, conservative or pessary treatment
was only considered for women with a mild degree of prolapse,
for those who wished to have more children, and the frail or those
unwilling to undergo surgery. However, 87% to 98% of clini-
cians report using pessaries in their clinical practice (Cundiff 2000;
Pott-Grinstein 2001; Gorti 2009) and 77% of gynaecologists re-
port using pessaries as first line treatment for prolapse (Cundiff
2000).
This is a review of treatment with pessaries (mechanical devices)
for prolapse. We will use the term ’pessary’ throughout the re-
view, with a pessary been defined as a passive mechanical device
designed to support the vagina. Other Cochrane reviews assess the
effectiveness of surgical, conservative and oestrogen based treat-
ments for prolapse (Ismail 2010; Maher 2010; Hagen 2011b) and
mechanical devices for urinary incontinence (Lipp 2011).
An extensive range of pessaries have been described for the treat-
ment of prolapse (Poma 2000; Oliver 2011). These consist mainly
of latex or silicone pessaries which are shaped devices that are in-
serted into and left in the vagina to support the prolapsed pelvic
organs. Two main groups of pessaries are used, support pessaries
and space filling pessaries (Oliver 2011). Study findings suggest
that ring pessaries are the type most commonly used in practice
(Cundiff 2000) but these may not be effective for all types of pro-
lapse.
How the intervention might work
Pessaries are used in pelvic organ prolapse in order to physically
support the vaginal walls and the pelvic organs behind them. The
pessary is inserted into the vagina with a view to holding the
prolapsed organs inside the vagina, supporting the pelvic struc-
tures, and relieving pressure on the bladder and bowel (Hay-Smith
2009). The aims of using a pessary in the management of pelvic
organ prolapse include to:
• prevent the prolapse becoming worse;
• help decrease the frequency or severity of symptoms of
prolapse;
• avert or delay the need for surgery (Oliver 2011).
Variable patterns of follow-up care are reported (Gorti 2009),
however pessaries do need to be removed regularly and the vagi-
nal mucosa checked for erosions. Some patients will be able to
remove and replace the pessary themselves, which may lengthen
the intervals between gynaecological examinations, while others
will return to the clinic for removal and replacement. Descriptive
data suggest that local oestrogens may be beneficial in success-
ful pessary fitting or in maintenance of treatment with pessaries
(Hanson 2006) but more evidence is needed about ongoing pes-
sary management. Pessaries are cheap and complications are re-
ported to be rare (Hanson 2006). The majority of evidence for the
use of pessaries comes from level II and III studies (Clemons 2004;
Clemons 2 2004; Clemons 3 2004; Hanson 2006; Kapoor 2009;
Lone 2011; Manchana 2012) thus the efficacy of pessary use in
the management of prolapse still requires to be clearly established.
Why it is important to do this review
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The wide variety of treatments available for prolapse indicates the
lack of consensus as to the optimal treatment. Provided that suffi-
cient numbers of trials of adequate quality have been conducted,
the most reliable evidence is likely to come from the consideration
of randomised controlled trials, and this is the basis for the present
review. The aim is to help identify optimal practice and highlight
where there is a need for further research.
O B J E C T I V E S
To determine the effectiveness of pessaries (mechanical devices)
for pelvic organ prolapse in women.
The following comparisons were considered:
1. any mechanical device versus control, waiting list or no active
treatment;
2. any mechanical device versus another treatment (lifestyle in-
terventions, oestrogen treatment, physical interventions such as
pelvic floor muscle training, surgery);
3. any mechanical device plus another treatment versus the other
treatment alone;
4. any mechanical device plus another treatment versus the me-
chanical device alone;
5. one mechanical device versus another mechanical device;
6. differing frequencies of device review or device change.
Other treatments could include: lifestyle interventions; oestrogen
treatment; physical interventions such as pelvic floor muscle train-
ing; surgery.
This review was designed to assess the effects of mechanical de-
vices which support prolapse. It did not assess devices designed to
improve pelvic floor muscle tone.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised or quasi-randomised controlled trials inwhich at least
one arm was a pessary (mechanical device intervention) for pelvic
organ prolapse.
Types of participants
Adult women seeking treatment for symptomatic pelvic organ
prolapse.
Pelvic organ prolapse included:
• anterior vaginal wall prolapse (cystocoele, urethrocoele);
• posterior vaginal wall prolapse (enterocoele, rectocoele,
perineal deficiency);
• uterine or vaginal vault prolapse.
Types of interventions
One arm of a trial involved allocation to a pessary (mechanical de-
vice) for prolapse. Comparison or concomitant interventions in-
cluded no treatment, lifestyle interventions, oestrogen treatment,
physical interventions such as pelvic floor muscle training, or
surgery.
The types of devices included:
1. support pessaries for unspecified prolapse including ring, ring
with support, Regula, Shaatz, Gellhorn, Gehrung, Hodge, Shelf,
Falk, and others;
2. space filling devices including donut, cube, inflatable ball, and
others.
Types of outcome measures
Primary outcomes
• Women’s perceived improvement in symptoms of prolapse
(e.g. assessed using validated symptom questionnaires)
Secondary outcomes
Subjective
• Acceptability or satisfaction with treatment
Objective
• Grade of prolapse with device in situ
• Site-specific grading of prolapse using Baden Walker or
Pelvic Organ Prolapse-Quantification (POP-Q) classification
(Bump 1996)
Quality of life
• Prolapse-specific quality of life questionnaire (e.g. P-QOL)
(Bump 1996)
• Generic quality of life or health status measures (e.g. SF 36)
(Ware 1993)
• Psychological outcome measures (e.g. HADS) (Zigmond
1983)
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Measures (objective or subjective) of associated symptoms
• Bladder problems, including urinary incontinence, occult
urinary incontinence, and relief of voiding difficulty
• Bowel problems, including relief of obstructed defecation
• Sexual problems, including acceptability of device to both
partners
Complications
• Ulceration, bleeding, discharge, need for removal, fistula
• Dislodgement, discomfort
• Urinary tract or bowel obstruction
• Incontinence, occult incontinence
• Incarceration
• Carcinoma
• Need for and reasons for device removal
Economic outcomes
• Costs of interventions
• Resource implications of the effects of treatment
• Measures of formal economic evaluations
Primary and secondary outcomes, as defined above, were classified
by the review authors as ’critical’, ’important’ or ’not important’
for decision making from the woman’s perspective. The GRADE
working group strongly recommends including up to seven critical
outcomes in a systematic review (Guyatt 2011a; Guyatt 2011b;
Guyatt 2013a; Guyatt 2013b).
In this systematic review, GRADE methodology was adopted for
assessing the quality of evidence for the following outcomes:
• woman’s perceived improvement in prolapse symptoms assessed
using validated symptom questionnaire at one year;
• acceptability of or satisfaction with treatment at one year;
• grade of prolapse with device in situ at one year.
Search methods for identification of studies
We did not impose any language or other restrictions on any of
the searches.
Electronic searches
This review has drawn on the search strategy developed for the
Cochrane Incontinence Review Group. Relevant trials were iden-
tified from the Incontinence Group Specialised Register of con-
trolled trials, which is described under the Incontinence Group
module inThe Cochrane Library. The Register contains trials iden-
tified from the Cochrane Central Register of Controlled Trials
(CENTRAL), MEDLINE, CINAHL, and handsearching of jour-
nals and conference proceedings. The date of the most recent
search of the Specialised Register for this review was 13 March
2012. The trials in the Incontinence Group Specialised Register
are also contained in CENTRAL. The terms used to search the
Incontinence Group trials register are given below:
({design.cct*} OR (design.rct*})
AND
{topic.prolapse*})
(All searches were of the keywords field of Reference Manager 12,
Thomson Reuters).
The search methods and strategies used for the previous version
of this review are given in Appendix 1.
Searching other resources
We handsearched the proceedings of two relevant conferences:
• Proceedings of the 41st Annual Meeting of the
International Continence Society (ICS), 2011, Aug 29 to Sept 2,
Glasgow, Scotland;
• Proceedings of the 36th Annual Meeting of the
International Urogynecological Association (IUGA), 2011, Jun
28 to Jul 2, Lisbon, Portugal.
The reference lists of relevant articles were also searched for other
possibly relevant trials.
Data collection and analysis
Data collection and analysis were conducted in accordance with
the Cochrane Handbook for Systematic Reviews of Interventions (
Higgins 2011).
Selection of studies
Our search generated a list of abstracts.Two review authors (DG
and CB) independently screened these abstracts. A third review
author (FMR) was nominated to arbitrate in the event of disagree-
ment. Studies which were not relevant were excluded at this stage.
The full text articles of relevant studies identified were obtained.
If there was any uncertainty on the eligibility of the studies based
on title and abstract, the full paper was obtained and reviewed
by the same two review authors. Studies formally considered for
the review but excluded were listed with reasons given for their
exclusion (see Characteristics of excluded studies). Our search is
summarised in Figure 1.
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Figure 1. PRISMA study flow diagram (for the current version of the review).
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Data extraction and management
Data extraction was undertaken independently by two review au-
thors (FMR and DG) using a predefined data extraction form
(Appendix 2) and comparisons made to ensure accuracy. Discrep-
ancies were resolved by discussion with, or referral to, a third party
(EA).
Assessment of risk of bias in included studies
The risk of bias within the study was assessed using the Cochrane
Incontinence Group risk of bias form (Appendix 3).
Measures of treatment effect
The primary outcome was a woman-reported outcome, the res-
olution of or improvement in the symptoms of prolapse (lump
or bulge). This can be assessed by standardised, validated patient
symptom questionnaires. Given there was only one trial included,
the treatment effect from that trial is described below and nometa-
analysis of treatment effect was possible.
Unit of analysis issues
The primary analysis was per woman randomised.
Dealing with missing data
Missing data is a common problem within trials, which can bias
the results. We have described missing outcomes (with reasons).
We addressed the potential impact of the missing outcomes and
we describe in the discussion section their impact on the findings
of the review.
Assessment of heterogeneity
Heterogeneity was not assessed as there was only one trial.
Assessment of reporting biases
Using the risk of bias form, we assessed for data that should have
been collected but were not reported.
Data synthesis
Our aim had been to try to combine the outcome measures from
the individual trials in ameta-analysis to provide a pooled effect es-
timate for each outcome, if the studies were clinically andmethod-
ologically comparable. However, as only one trial was included
this was not possible.
Subgroup analysis and investigation of heterogeneity
Wewouldhave carried out subgroup analysis according todifferent
prolapse compartments (for example upper versus lower) if data
had been available. An investigation of heterogeneity could not be
undertaken as there was only one trial.
Sensitivity analysis
Sensitivity analysis was not undertaken as there was only one trial.
R E S U L T S
Description of studies
See: Characteristics of included studies; Characteristics of studies
awaiting classification.
See ’Characteristics of included studies’; ’Characteristics of studies
awaiting classification’.
Results of the search
In the previous review no randomised controlled trials (RCTs) of
pessaries for women with pelvic organ prolapse were identified.
In the current review we assessed a further 31 records and found
one eligible RCT (Cundiff 2007) and one (Hagen 2011) that is
awaiting classification. The flow of literature through the assess-
ment process for the update of this review is shown in Figure 1.
Included studies
Cundiff 2007 reported a randomised crossover trial comparing
symptom relief and the change in life impact for women using
ring with support versus Gellhorn pessaries. The study was multi-
centre and performed in the USA. The trial included 134 women
presenting with symptomatic pelvic organ prolapse, stage II or
greater on the POP-Q classification (Bump 1996). Women were
randomised to each pessary using computer generated random
numbers allocated in sealed opaque envelopes. Neither women
nor researchers were blinded to the allocated pessary, but data
were coded to permit blinding during analysis. Those women who
were successfully fitted were asked to wear the pessary for three
months, but if they discontinued prior to three months the data
collection was accelerated. Outcome measures included changes
in the Pelvic Floor Distress Inventory (PFDI) and the Pelvic Floor
Impact Questionnaire (PFIQ) (Barber 2001). The study reported
both statistically significant and clinically significant changes in
the PFDI and PFIQ. Clinically significant changes were defined
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as a change greater than half the standard deviation of the pre-
intervention score (Sloan 2005).
Excluded studies
Studies awaiting classification
One study (Hagen 2011) is being considered for inclusion. Both
intervention and control groups had a pessary fitted, with the in-
tervention group also having pelvic floormuscle training (PFMT).
This trial is awaiting classification for possible inclusion in the
next update of the review.
Risk of bias in included studies
Please see Figure 2 for a visual representation of the risk of bias
factors in the included trial.
Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
In the trial, randomisation assigned participants to one of two
groups that differed in the sequence of pessary use, andparticipants
were assigned to the two groups with equal probability. Randomi-
sation used computer generated random numbers in permuted
blocks of variable size (six to 10) and allocated by sealed opaque
envelopes.
Blinding
Blinding of participants and clinicians was not feasible however the
trial did code data collection to permit blinding during analysis.
Incomplete outcome data
Attrition rates in the study were very high with only 85 of the 134
women completing the study and some of these had data collection
accelerated that is collected before the primary end point of three
months.
Selective reporting
The authors described many outcome measures in the methods of
the study. These included POP-Q, pelvic muscle grading, assess-
ment of perineal descent, atrophy, erosions, wet prep, PFDI and
PFIQ, a validated sexual function questionnaire, and a patient sat-
isfaction visual analogue scale. However only the PFDI and PFIQ
and associated subscales were reported.
Bias related to crossover design
One small study published in the literature (Handa 2002) sug-
gested that pessaries may improve the stage of prolapse. Although
Handa measured outcomes at one year, the findings did raise the
possibility of a carryover effect in the crossover design.
Other potential sources of bias
No other potential sources of bias were identified.
Effects of interventions
See: Summary of findings for the main comparison Pessaries
(mechanical devices) for pelvic organ prolapse in women
Trial resultswere reported under the appropriate comparisonhead-
ing.
1. Any mechanical device versus control, waiting list or no active
treatment
No trials identified.
2. Any mechanical device versus another treatment (lifestyle in-
terventions, oestrogen treatment, physical interventions such as
pelvic floor muscle training, surgery).
No trials identified.
3. Any mechanical device plus another treatment versus the other
treatment alone.
No trials identified.
4. Anymechanical device plus another treatment versus amechan-
ical device alone.
One trial awaiting classification (Hagen 2011).
5. One mechanical device versus another mechanical device.
One trial was identified (Cundiff 2007) comparing a ring with
support versus aGellhorn pessary. The outcomemeasures reported
were the PFDI (3 subscales: POPDI, CRADI, UDI) and PFIQ (3
scales: CRAIQ, POPIQ, IIQ each with 4 subscales: travel, social,
emotional, physical).
Both the POPDI and POPIQ scales and subscales measured sta-
tistically significant changes from baseline for both pessaries. Clin-
ically significant changes from baseline were also found in the
POPDI for both the ring and the Gellhorn and a clinically sig-
nificant change from baseline in POPIQ was found for the Gell-
horn. However, there were no significant differences in terms of
improvement in POPDI or POPIQ, statistical or clinical, in di-
rect comparisons between the ring with support and the Gellhorn
pessaries.
The Urinary Distress Inventory (UDI) and Urinary Impact Ques-
tionnaire (UIQ) scales and subscales showed statistical and clinical
improvement from baseline for both pessaries but no difference
between the two pessaries. TheColorectal-AnalDistress Inventory
(CRADI) showed a statistically and clinically significant improve-
ment from baseline but no difference between the two pessaries.
However, the Colorectal-Anal Impact Questionnaire (CRAIQ)
only showed a statistically significant difference but not a clinically
significant improvement for both pessaries.
Cundiff and colleagues did not report the outcomes selected for
GRADE, as illustrated in the Summary of findings for the main
comparison.
6. Differing frequencies of device review or device change.
No trials identified.
D I S C U S S I O N
This updated review considers whether pessaries (mechanical de-
vices) are effective in the management of pelvic organ prolapse.
The scope of the review has not been changed. Reviews relating to
alternative forms of treatment for pelvic organ prolapse are covered
in other Cochrane reviews, surgery (Maher 2010), conservative
methods such as pelvic floor muscle training and lifestyle changes
(Hagen 2011b) and oestrogen (Ismail 2010).
Since the last review only one randomised controlled trial has been
identified (Cundiff 2007). This trial had a high attrition rate lead-
ing to high risk of bias. However, the trial was not underpow-
ered due to the crossover design. In this study it was reported that
approximately 60% of women offered a pessary would continue
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with the treatment in the long term regardless of which device
they used. This low continuation and high attrition factor should
be considered in future study designs.
The use of pessaries has become commonplace over many years
without full evaluation of their efficacy in comparison to other
modes of treatment such as surgery, oestrogens or pelvic floormus-
cle training (PFMT). There is a need for trials of the effectiveness
of pessaries in comparison to other treatments. There is a need for
trials to assess whether early use of pessaries prevents progression
of prolapse. There is also a need for trials which address the indica-
tion for pessary use and the care of pessaries; at present there is no
consensus on the intervals between pessary changes, the treatment
of complications, the role of local oestrogens or other concomi-
tant treatments such as PFMT, nor which pessaries are indicated
in specific types of pelvic organ prolapse. Despite their common
usage, there are wide gaps in our knowledge of the outcomes of
treatment using pessaries, which should be remedied with well-
designed RCTs.
Summary of main results
The only RCT reported to date (Cundiff 2007) comparing ring
pessaries with support to Gellhorn pessaries found no statistically
significant difference in symptom scores (PFDI and PFQI) be-
tween the two pessaries.
Overall completeness and applicability of
evidence
With only one relatively small, USA based trial, the data lack the
completeness to be widely applicable to international practice.
Quality of the evidence
Cundiff and colleagues did not report the outcomes selected for
GRADE, as illustrated in the Summary of findings for the main
comparison.
Potential biases in the review process
None noted.
Agreements and disagreements with other
studies or reviews
The previous Cochrane review did not identify any trials for in-
clusion. This review provides evidence from one relevant trial.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
No good quality evidence from randomised controlled trials was
identified onwhich to base themanagement by pessaries ofwomen
with pelvic organ prolapse. The only randomised controlled trial
that was reported highlighted a high attrition rate of up to 40%,
which needs to be taken into account in the design of randomised
controlled trials of pessaries for pelvic organ prolapse in the future.
Implications for research
There is a need for well-designed randomised controlled trials in
this area. Specifically the following comparisons should be made:
1. a pessary versus control, waiting list or no active treatment;
2. a pessary versus surgery;
3. a pessary versus physical interventions such as pelvic floormuscle
training (PFMT) or lifestyle changes.
These trials should also evaluate whether there is any additional
risk or benefit from the use of local oestrogen therapy or PFMT
in conjunction with a pessary. In addition, trials are needed to
inform the best ways to manage long term pessary use.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by year of study]
Cundiff 2007
Methods Multicentre randomised crossover trial
Participants 134 women with symptomatic pelvic organ prolapse of stage II or greater on POP-Q
(Bump1996). 54%ofwomenhad apredominantly anterior compartment prolapse; 35%
a predominantly apical compartment and 10% a predominately posterior compartment
prolapse
Interventions Ring pessary with support or Gellhorn pessary
Outcomes Outcomes were assessed at 1 week, 6 weeks and 12 weeks and at time of drop out.
Multiple outcome measures were reported in the methods (PFDI, PfIQ, VAS, POP-
Q, perineal descent, perineal reflexes, atrophy, erosions and wet prep). The study power
calculation was based on the outcome “symptom relief ”, which probably equates to the
POP-DI outcome. However no primary outcome was formally stated
Notes This study had a very high drop-out rate: only 85 of the original 134 completed the
study. However some results appear to have been reported on the total number 134.
Most results do not specify the number of subjects
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomization used computer-generated
random numbers in permuted blocks of vari-
able size (6-10).” Initial randomisation appro-
priate however then patient preference took
priority over randomisation. Although these
patients were then excluded from the analysis
it may affect the results
Allocation concealment (selection bias) Low risk “allocated by sealed opaque envelopes”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk It was not possible to blind patients to the type
of pessary used because they were taught to
remove them
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The data collectedwere coded to permit blind-
ing during the analysis of results
Incomplete outcome data (attrition bias)
All outcomes
High risk The study had a high drop-out rate: only 85
of the 134 completed the study
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Cundiff 2007 (Continued)
Selective reporting (reporting bias) High risk There was no formally stated primary out-
come. Not all of the outcomes described in
the methods have been reported in the re-
sults. There is no report on vaginal discharge
or bleeding
Appropriateness of cross-over design Unclear risk There is some suggestion in the literature (
Handa 2002) that pessaries may improve the
stage of prolapse therefore there is the potential
for a carryover effect
Randomised treatment order Low risk Random allocation was by computer gener-
ated random numbers using permuted blocks
of variable size. Allocation was stored in
opaque sealed envelopes
Risk of carry-over effects Unclear risk Given the possibility of pessaries improving
stage of prolapse (Handa 2002) there may be
some risk of carryover effect
Characteristics of studies awaiting assessment [ordered by study ID]
Hagen 2011
Methods RCT
Participants 16 women with symptomatic pelvic organ prolapse of POP-Q stage I-IV (8 intervention and 8 control)
Interventions Pessary plus PFMT versus pessary alone
Outcomes
Notes
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Search methods and strategies for the extra specific searches conducted for the
previous version of this review (October 2005)
Electronic Databases
MEDLINE (January 1966 to Week 5 August 2005) was searched on 14 September 2005 and PREMEDLINE (15 September 2005)
was searched on 19 September 2005, both on OVID, using the following search terms:
1.prolapse/
2.uterine prolapse/
3.Rectocele/
4.(prolaps$ adj5 (pelvi$ or vagin$ or genit$ or uter$ or vault$ or apical or urethr$ or segment$ or wall$)).tw.
5.cystoc?ele$.tw.
6.rectoc?ele$.tw.
7.urethroc?ele$.tw.
8.enteroc?ele$.tw.
9.proctoc?ele$.tw.
10.sigmoidoc?ele$.tw.
11.(pelvi$ adj3 dysfunct$).tw.
12.(pelvi$ adj3 (disorder$ or relax$)).tw.
13.(vagin$ adj3 defect$).tw.
14.(urogenital adj5 prolaps$).tw.
15.(cervi$ adj5 prolaps$).tw.
16.or/1-15
This set of terms was combined with the first two parts of the Cochrane Highly Sensitive Search Strategy for randomised controlled
trials (Appendix 5b.2, Cochrane Handbook, version 4.2, March 2003) using the Boolean operator ’AND’.
EMBASE (January 1996 to Week 43 2005) was searched on 25 October 2005, on OVID, using the following search terms:
1.pelvic adj5 prolaps$.tw.
2.uterus prolapse/
3.rectocele/
4.vagina prolapse/
5.cystocele/
6.or/1-5
7.randomised controlled trial/
8.controlled study/
9.clinical study/
10.major clinical study/
11.prospective study/
12.meta analysis/
13.exp clinical trial/
14.randomisation/
15.crossover procedure/ or double blind procedure/ or parallel design/ or single blind procedure/
16.placebo/
17.latin square design/
18.exp comparative study/
19.follow up/
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20.pilot study/
21.family study/ or feasibility study/ or study/
22.placebo$.tw.
23.random$.tw.
24.(clin$ adj25 trial$).tw.
25.((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.
26.factorial.tw.
27.crossover.tw.
28.latin square.tw.
29.(balance$ adj2 block$).tw.
30.or/7-29
31.(nonhuman not human).sh.
32.30 not 31
33.6 and 32
CINAHL (January 1982 to February Week 4 2003) was searched on 13 March 2003, on OVID, using the following search terms:
1.exp pelvic organ prolapse/
2.genital diseases, female/
3.prolapse/
4.uterine prolapse/
5.Rectocele/
6.(prolaps$ adj5 (pelvi$ or vagin$ or genit$ or uter$ or vault$ or apical or urethr$ or segment$ or wall$)).tw.
7.cystoc?ele$.tw.
8.rectoc?ele$.tw.
9.urethroc?ele$.tw.
10.enteroc?ele$.tw.
11.proctoc?ele$.tw.
12.sigmoidoc?ele$.tw.
13.(pelvi$ adj3 dysfunct$).tw.
14.(pelvi$ adj3 (disorder$ or relax$)).tw.
15.(vagin$ adj3 defect$).tw.
16.(urogenital adj5 prolaps$).tw.
17.(cervi$ adj5 prolaps$).tw.
18.((descen$ adj2 (uter$ or genit$ or pelv$)).tw.
19.procident$.tw.
20.(vagin$ adj2 (eversion$ or evert$)).tw.
21.(hernia$ adj2 (bladder$ or cystic or vesico$)).tw.
22.(bladder$ adj2 protru$).tw.
23.(viscer$ adj2 prolap$).tw.
24.hysteropex$.tw.
25.or/1-2
26.placebo$.tw.
27.random$.tw.
28.(clin$ adj25 trial$).tw.
29.((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).tw.
30.factorial.tw.
31.crossover.tw.
32.latin square.tw.
33.(balance$ adj2 block$).tw.
34.or/26-33
35.25 and 34
PEDro (the Physiotherapy Evidence Database) (url: www.pedro.fhs.usyd.edu.au) produced by the Centre for Evidence-Based Physio-
therapy (CEBP), University of Sydney, Australia was searched on 13 October 2003 using the search term “prolapse”.
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The UK National Research Register (Issue 3, 2003), Controlled Clinical Trials (April 2003) and ZETOC database of conference
abstracts (April 2003) were searched using the search terms cystocele, urethrocele, rectocele, vault prolapse, uterine prolapse, vaginal
prolapse, pelvic organ prolapse, pelvic floor.
The reference lists of relevant articles were searched for other possibly relevant trials, including the Cochrane review (Hay-Smith 2001)
of pelvic floor muscle training for urinary incontinence.
We did not impose any language or other restrictions on any of the searches.
Appendix 2. Data extraction form
MECHANICAL DEVICES FOR PROLAPSE: TRIAL CHARACTERISTIC FORM
REF ID ˙˙˙˙˙˙˙˙˙˙˙˙˙˙
REF NO˙˙˙˙˙
TYPE OF PUBLICATION
(abstract, proceeding, full text, translated, etc)
METHODS
Description of randomization
Stratification?
No. of treatment arms?
Allocation concealment?
Blinding?
Patient
Care giver
Assessor
Power calculation?
Intention to treat analysis?
Follow up
PARTICIPANTS
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(Continued)
Total study population
Withdrawals
Diagnosis by :
Symptom /VE/POP-Q/ultrasound
Type of prolapse
Severity of prolapse
Urinary incontinence present
Inclusion criteria
Exclusion criteria
Baseline comparison of treatment groups?
Characteristic of population (age, parity, etc)
No. of centres
Type of centre
Location
INTERVENTION
Comparisons
Description / Variation
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(Continued)
Types of pessary fitted?
Who fitted pessary?
(surgeon/physiotherapist/ nurse)?
Follow up care?
Who?
Frequency?
Is pessary refitted?
Frequency of refitting?
OUTCOME
List all
Definition of symptom alleviation
Other definitions
Proportion of women who progress to surgery [timescale and
surgery type]
OTHER NOTES / COMMENTS
MECHANICAL DEVICES FOR PROLAPSE: DATA ABSTRACTION FORM
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REF ID ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙
REF NO ˙˙˙˙˙˙˙
COMPARISONS I : ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙ II : ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙ III : ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙
Outcome Units I II III
A. Patients’ observa-
tions
perceived alleviation of
prolapse symptoms
acceptability/ satis-
faction with outcome of
treatment
B. Objective measures
grade of prolapse with
device in situ judged on
clinical examination e.g.
(which system?? - ICS
POP-Q system (Bump
1996)
Site-specific grading of
prolapse judged on clini-
cal examination e.g. ICS
POP-Q system (Bump
1996)
C. Quality of Life
prolapse-specific quality
of life questionnaire e.g.
P-QoL (Bump 1996)
generic quality of life or
health status measures e.
g. SF-36 (Ware 1992)
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(Continued)
psychological outcome
measures e.g. Hospital
Anxiety and Depression
Score (Zigmond 1983)
D. Measures of Associ-
ated Symptoms
bladder problems (in-
cluding UI, occult UI,
relief of voiding diffi-
culty)
bowel problems (includ-
ing relief of obstructed
defaecation)
sexual function (includ-
ing acceptability to both
partners)
E. Complications
associated with pessary
use: fistula formation, ul-
ceration, bleeding, dis-
charge etc. [record all
complications]
Reasons for device re-
moval
F. Socio-economic eval-
uations
cost comparisons
NOTES
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Appendix 3. Risk of Bias assessment form
The Cochrane Incontinence Group
Risk of Bias Form
TITLE OF POTENTIAL INCLUDED STUDY:
FIRST AUTHOR:
JOURNAL:
YEAR:
VOLUME/NUMBER:
PAGES: ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙
Name of review: ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙
Name of review author: ˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙˙
To be completed by the review author
Is the study relevant to the above review?
Yes o No o
Is the study a randomised or quasi-randomised trial?
(quasi-randomised = alternation, day of week etc)
Yes o Unclear o No o
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WH A T ’ S N E W
Last assessed as up-to-date: 13 March 2012.
Date Event Description
22 January 2013 New search has been performed Identified one new study Cundiff 2007
22 January 2013 New citation required but conclusions have not changed Reviewupdated, one new study identifiedCundiff 2007
H I S T O R Y
Protocol first published: Issue 1, 2003
Review first published: Issue 2, 2004
Date Event Description
7 August 2008 Amended Converted to new review format.
26 January 2006 New search has been performed Minor update: 26/01/06 New studies sought but none
found: 26/10/05
25 February 2004 New citation required and conclusions have changed Review first published
C O N T R I B U T I O N S O F A U T H O R S
FMR reviewed documents, extracted data and co-produced the final review.
CB co-produced the final review.
DG extracted data and along with CB reviewed abstracts and included studies.
DG and EJA contributed to writing the final review.
D E C L A R A T I O N S O F I N T E R E S T
None known
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S O U R C E S O F S U P P O R T
Internal sources
• No sources of support supplied
External sources
• NIHR, UK.
The Cochrane Incontinence Review Group is supported by NIHR UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
None
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Pessaries; Pelvic Organ Prolapse [∗therapy]; Randomized Controlled Trials as Topic; Rectal Prolapse [∗therapy]; Urethral Diseases
[therapy]; Urinary Bladder Diseases [therapy]; Uterine Prolapse [therapy]
MeSH check words
Female; Humans
26Pessaries (mechanical devices) for pelvic organ prolapse in women (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
